Gsk Share Discussion Threads

[tradermichael] 16/10/2020 14:34

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

-- ViiV Healthcare's Vocabria (cabotegravir injection) used in combination with Janssen Pharmaceutical Companies of Johnson & Johnson's Rekambys (rilpivirine injection) reduces treatment dosing days from 365 to 12 or 6 per year

-- Long-acting regimen is based on co-administration of cabotegravir and rilpivirine injections once-monthly or once every 2-months to treat HIV-1

-- Vocabria (cabotegravir) tablets for use as an oral lead-in therapy with Edurant (rilpivirine tablets) prior to starting the long-acting regimen also receives positive CHMP opinion

[montyhedge] 16/10/2020 12:09

Thanks bears for my early Xmas present yesterday. Could not believe the price.

[bogman1] 16/10/2020 09:46

Unreasonably low. Might drop a bit further next week tho with boris the bozo and his negotiating skills, but feels like near the bottom. For LT investor anytime now is a good time to go in I reckon

[geckotheglorious] 16/10/2020 09:18

William

"Higher taxes,higher inflation - easy to make money"



Pray do tell how. Whatever money you make will be both worth less, and more of it will be stolen from you!

[montyhedge] 16/10/2020 08:40

What a price yesterday at 1376p picked some up, sellers gave bulls an early Xmas present, lol

[montyhedge] 16/10/2020 07:55

Seems ridiculously oversold. Gift from the stock market gods. 5.81% safe yield.

[bogman1] 16/10/2020 01:12

I reckon we could hit a bottom or certainly close on this one as well spud. As you say. I would know :)

[lippy4] 15/10/2020 23:27

in for more today we will see if this is the bottom????

[spud] 15/10/2020 22:58

Happy to take advantage of the Market's lowball valuation! Long may it continue. spud

[montyhedge] 15/10/2020 22:45

Certainly oversold today, bounce coming.

[williamcooper104] 15/10/2020 18:16

Yep - but if we get a blue tide we'll have mega stimulus and potentially even the return of inflation Higher taxes and higher inflation Easy to make money

[geckotheglorious] 15/10/2020 17:37

If Biden wins, he'll be Potus for 6-8 months max before being declared senile and forced to stand down.
Then you get Socialist authoritarian Kamala Harris.

Drug pricing will be the least of our worries

[williamcooper104] 15/10/2020 17:36

I'm holding this with a lot of US renewable/renewable development stocks - so even if blue wave kills drug prices ought to be ok

[essentialinvestor] 15/10/2020 17:06

Depends on margin of victory.

US markets becalmed and near all time highs with Biden's estimated
margin of victory atm, a close result is what markets don't want.

In terms of GSK under Biden, lots of noise on drug pricing,
May be a few measures, not a major threat imv.

Trump talked plenty tough on pricing in 2016 and since, achieved arguably nothing.

Less than nothing as costs are well ahead of wider inflation over the last 4 years.

[amaretto1] 15/10/2020 16:53

What's safe about it ? If Biden wins .. all hell will let lose

[amaretto1] 15/10/2020 16:53

i can see spuds 1300 !! On the 5 year chart ....I'll reconsider at 13.50

[montyhedge] 15/10/2020 16:52

Safe 5.81% yield.

[amaretto1] 15/10/2020 16:51

Near as dam it

[amaretto1] 15/10/2020 16:50

Well it's hit my 13.75 ...I'm looking at between 13.50- 13.75 !!And sticking to it...Unless dollar collapses

[essentialinvestor] 15/10/2020 16:39

13.76 in acution, so that's pretty much 13.70 there on the close.

Did have a look of that area, but was just a guessestimate.

[geckotheglorious] 15/10/2020 16:30

BioNTech (NASDAQ:BNTX) and partner Pfizer (NYSE:PFE) haven't had to stop their late-stage COVID-19 vaccine study over safety concerns, BioNTech CEO Ugur Sahin told Bloomberg, after publishing some of the data they used to narrow their candidate from a slate of four contenders.

Because of the structure of the trial, the companies had first disclosed early results for another vaccine candidate, BNT162b1, in July. Investors had been optimistic about its prospects, but after comparing data, the firms decided instead to pursue another candidate, BNT162b2.

BioNTech and Pfizer are still sticking with their previously announced target of being able to provide preliminary data on whether the mRNA vaccine works as soon as this month, if a threshold for infections is reached. Any submissions for regulatory approval would come later.

[essentialinvestor] 15/10/2020 13:55

£13 may need to be accompanied by adverse trading news imv.
But they have spelt out and underlined in red the impact of lower
vaccine take up.

That's one of the reasons why any comparison with AZN is erroneous

[rikky72] 15/10/2020 13:51

I think it's more or less a complete unknown to everyone, whether bull or bear. It certainly clouds being a able to take a clear view of the medium to long term here until it is done, or at the very least, specific details emerge.